Spyre Therapeutics (SYRE) Share-based Compensation (2015 - 2026)
Spyre Therapeutics (SYRE) recorded Share-based Compensation of $13.51 million in Q2 2026, up 44.1% from $9.38 million a year earlier and up 5.5% from the prior quarter.
Powered by 
Analysis
Spyre Therapeutics (SYRE) Share-based Compensation (2015 - 2026) Analysis & Trends
On a TTM basis, Spyre Therapeutics' Share-based Compensation came in at $45.7 million as of Jun 30, 2026, up 12.7% year-over-year; for FY2025, it was $37.61 million, down 16.1% from FY2024.
- Annual Share-based Compensation has a five-year compound annual growth rate of 43.2% (FY2020 to FY2025).
- Across earlier years, Share-based Compensation came in at $44.83 million in FY2024 (+74.6%), $25.68 million in FY2023 (+261.1%), $7.11 million in FY2022 (-11.5%) and $8.04 million in FY2021 (+28.5%).
- The Q2 2026 figure is the highest quarterly Share-based Compensation since Q1 2024.
- On a year-over-year basis, Share-based Compensation has increased for three consecutive quarters, with growth averaging 20.8% over the last eight quarters.
- Peak year-over-year performance for Share-based Compensation in the last five years was growth of 709.5% in Q1 2024, against a decline of 46.6% in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $12.81 million (Q1 2026), $9.81 million (Q4 2025) and $9.57 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | - |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Spyre Therapeutics | 7.46 Bn | 7.46 Bn | - | 13.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.51 Mn |
| Mar 31, 2026 | 12.81 Mn |
| Dec 31, 2025 | 9.81 Mn |
| Sep 30, 2025 | 9.57 Mn |
| Jun 30, 2025 | 9.38 Mn |
| Mar 31, 2025 | 8.86 Mn |
| Dec 31, 2024 | 9.22 Mn |
| Sep 30, 2024 | 13.10 Mn |
| Jun 30, 2024 | 8.70 Mn |
| Mar 31, 2024 | 13.84 Mn |
| Dec 31, 2023 | 17.27 Mn |
| Sep 30, 2023 | 4.80 Mn |
| Jun 30, 2023 | 1.90 Mn |
| Mar 31, 2023 | 1.71 Mn |
| Dec 31, 2022 | 1.43 Mn |
| Sep 30, 2022 | 1.57 Mn |
| Jun 30, 2022 | 2.02 Mn |
| Mar 31, 2022 | 2.10 Mn |
| Dec 31, 2021 | 2.09 Mn |
| Sep 30, 2021 | 2.11 Mn |
API Access
Spyre Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=SYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "SYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=SYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();